A study from South Korea found that oral bacteria, once settled in the gut, can release metabolites that damage brain neurons and trigger Parkinson's disease. Researchers identified Streptococcus mutans and its metabolite imidazole propionate as key culprits. Targeting gut microbiota and related pathways may open new treatment options for Parkinson's.